Psychological Impact of Screening for Familial Ovarian Cancer: Reactions to Initial Assessment
作者： Gail Erlick Robinson , Barry P. Rosen , Linda N. Bradley , Wendy G. Rockert , Melanie L. Carr
关键词:
摘要: Abstract Objectives: To assess the psychological impact on women attending a familial ovarian cancer screening clinic. Study Methods: 157 referred for completed an investigator designed questionnaire, Spielberger State Trait Anxiety Scale and Centre Epidemiological Studies Depression prior to interview eight-item questionnaire post-assessment. Results: 95.4% saw as valuable. Thirty-one point four percent of all patients scored about cutoff depression. Sixteen exhibited high levels anxiety. Fifty-six accurately perceived their risk. Twenty-one five those who themselves being at risk had anxiety 40.6% reported significant depressive symptoms. Of 26.5% overestimated risks, 40.0% symptoms 22.6% were anxious. 17.1% minimized risk, none anxious (0.0%), only 15.8% depressed. Conclusion: Attendees clinic may have depression
gynecologiconcology-online.net
elsevier.com
sci-hub.se 参考文章(34)
Caroline M Benjamin, S Adam, Sandi Wiggins, JL Theilmann, TT Copley, M Bloch, F Squitieri, W McKellin, S Cox, SA Brown, HPH Kremer, M Burgess, W Meshino, A Summers, D Macgregor, J Buchanan, C Greenberg, N Carson, E Ives, M Frecker, JP Welch, A Fuller, D Rosenblatt, S Miller, S Dufrasne, M Roy, E Andermann, C Prevost, M Khalifa, K Girard, S Taylor, A Hunter, C Goldsmith, D Whelan, D Eisenberg, H Soltan, J Kane, MHK Shokeir, A Gibson, S Cardwell, S Bamforth, S Grover, O Suchowersky, M Klimek, T Garber, HA Gardner, P MacLeod, MR Hayden, Proceed with Care: Direct Predictive Testing for Huntington Disease American Journal of Human Genetics. ,vol. 55, pp. 606- 617 ,(1994)
T C Heeren, J R Sorenson, D C Wertz, Clients' interpretation of risks provided in genetic counseling. American Journal of Human Genetics. ,vol. 39, pp. 253- 264 ,(1986)
B. Rosen, D. E. C. Cole, S. Gallinger, D. Malkin, J. Engel, D. R. Mccready, Genetic counselling and testing for susceptibility to breast, ovarian and colon cancer: where are we today? Canadian Medical Association Journal. ,vol. 154, pp. 149- 155 ,(1996)
H G Stoate, Can health screening damage your health The Journal of the Royal College of General Practitioners. ,vol. 39, pp. 193- 195 ,(1989)
C Lerman, M Daly, A Masny, A Balshem, Attitudes about genetic testing for breast-ovarian cancer susceptibility. Journal of Clinical Oncology. ,vol. 12, pp. 843- 850 ,(1994) , 10.1200/JCO.1994.12.4.843
T H Bourne, S Campbell, K M Reynolds, M I Whitehead, J Hampson, P Royston, T J Crayford, W P Collins, Screening for early familial ovarian cancer with transvaginal ultrasonography and colour blood flow imaging. BMJ. ,vol. 306, pp. 1025- 1029 ,(1993) , 10.1136/BMJ.306.6884.1025
Ford, D, Easton, DF, Bishop, DT, Narod, SA, Goldgar, DE and the Breast Cancer Linkage Consortium, None, Risks of cancer in BRCA1-mutation carriers The Lancet. ,vol. 343, pp. 692- 695 ,(1994) , 10.1016/S0140-6736(94)91578-4
JoanneK. Tobacman, MargaretA. Tucker, Ronald Kase, MarkH. Greene, Jose Costa, JosephF. Fraumeni, INTRA-ABDOMINAL CARCINOMATOSIS AFTER PROPHYLACTIC OOPHORECTOMY IN OVARIAN-CANCER-PRONE FAMILIES The Lancet. ,vol. 320, pp. 795- 797 ,(1982) , 10.1016/S0140-6736(82)92681-2
R Ellman, N Angeli, A Christians, S Moss, J Chamberlain, P Maguire, Psychiatric morbidity associated with screening for breast cancer. British Journal of Cancer. ,vol. 60, pp. 781- 784 ,(1989) , 10.1038/BJC.1989.359
Andrew M. Kaunitz, Oral contraceptives and gynecologic cancer: an update for the 1990s. American Journal of Obstetrics and Gynecology. ,vol. 167, pp. 1171- 1176 ,(1992) , 10.1016/S0002-9378(12)90407-X